Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypermethylation”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT04260074
What this trial is testing

Epigenetic Changes in Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma+1 more
Aalborg University Hospital 40
Not applicableUnknownNCT05624827
What this trial is testing

The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2DNA Methylation
University Medical Centre Maribor 100
Testing effectiveness (Phase 2)Study completedNCT01193517
What this trial is testing

Azacitidine and CAPOX in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 26
Not applicableStudy completedNCT01209520
What this trial is testing

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Who this might be right for
Lung CancerNon Small Cell Lung CarcinomaHypermethylation
University of Miami 6
Testing effectiveness (Phase 2)UnknownNCT00674167
What this trial is testing

The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 21
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Testing effectiveness (Phase 2)Study completedNCT00293280
What this trial is testing

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Large-scale testing (Phase 3)Active Not RecruitingNCT02152982
What this trial is testing

Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcoma
National Cancer Institute (NCI) 447
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662
What this trial is testing

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 39
Not applicableStudy completedNCT04177316
What this trial is testing

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

Who this might be right for
Hepatocellular Carcinoma Resectable
Chang Gung Memorial Hospital 92
Not applicableStudy completedNCT01663298
What this trial is testing

Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics

Who this might be right for
SmokingDiabetes
University of North Carolina, Chapel Hill 44
Not applicableUnknownNCT02079363
What this trial is testing

DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer

Who this might be right for
Pancreatic DiseasesPancreatic NeoplasmsPancreatitis
Aalborg University Hospital 330